Related Experiment Video

Updated: Jun 24, 2025

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
06:09

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on: June 7, 2019

8.7K

Fustin suppressed melanoma cell growth via cAMP/PKA-dependent mechanism

Motofumi Kumazoe1, Yoshinori Fujimura1, Yu Shimada1

  • 1Division of Applied Biological Chemistry, Department of Bioscience and Biotechnology, Faculty of Agriculture, Kyushu University, Fukuoka, Japan.

Bioscience, Biotechnology, and Biochemistry
|June 5, 2024
PubMed

Insights

Fustin, a natural compound, effectively inhibits melanoma cell growth by altering actin structure and impacting key regulatory proteins. This compound shows promise as a novel therapeutic for melanoma, with no observed adverse effects in mouse models.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Pharmacology

Background:

  • Melanoma treatment is challenging due to conventional therapy ineffectiveness in some patients.
  • Fustin, a flavanonol from young fustic (Cotinus coggygria), has potential but uncharacterized antimelanoma effects.

Purpose of the Study:

  • To investigate the antimelanoma effects of fustin.
  • To elucidate the molecular mechanisms underlying fustin's action against melanoma cells.

Main Methods:

  • In vitro studies using B16 melanoma cells and phalloidin staining for cytoskeletal actin.
  • Analysis of myosin regulatory light chain 2 (MLC2) phosphorylation and myosin phosphatase targeting subunit 1.
  • In vivo studies using a mouse model of melanoma.

Main Results:

  • Fustin suppressed B16 melanoma cell growth in vitro.
  • Fustin induced conformational changes in melanoma cell actin structure.
  • Fustin inhibited MLC2 phosphorylation and affected myosin phosphatase targeting subunit 1 signaling.
  • Fustin administration suppressed melanoma tumor growth in mice without adverse effects.

Conclusions:

  • Fustin demonstrates significant antimelanoma activity both in vitro and in vivo.
  • Fustin's mechanism involves modulation of the actin cytoskeleton and associated signaling pathways.
  • Fustin represents a potential novel therapeutic agent for melanoma treatment.
Keywords:
cAMPcancerfustinmelanomaphytochemicals

More Related Videos

Pharmacologic Induction of Epidermal Melanin and Protection Against Sunburn in a Humanized Mouse Model12:37

Pharmacologic Induction of Epidermal Melanin and Protection Against Sunburn in a Humanized Mouse Model

Published on: September 7, 2013

18.2K
A Novel Stromal Fibroblast-Modulated 3D Tumor Spheroid Model for Studying Tumor-Stroma Interaction and Drug Discovery07:20

A Novel Stromal Fibroblast-Modulated 3D Tumor Spheroid Model for Studying Tumor-Stroma Interaction and Drug Discovery

Published on: February 28, 2020

9.9K

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.4K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K